Regen BioPharma Inc (17)
Browse by Contract Category
Contracts
-
REGEN BIOPHARMA, INC
(Filed With SEC on April 16, 2021)
-
Form of Convertible Note $100,000
(Filed With SEC on August 29, 2019)
-
KCL Agreement
(Filed With SEC on April 8, 2021)
-
Regen Agreement
(Filed With SEC on April 8, 2021)
-
AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND TODD S. CAVEN
(Filed With SEC on March 25, 2021)
-
Form of Amendment Convertible Note
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $20,331
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $14,819
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note 50,000
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $63,000
(Filed With SEC on February 12, 2019)
-
Form of Note Receivable $50,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $50,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $50,000
(Filed With SEC on February 12, 2019)
-
Form of Note Receivable $63,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $75,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $63,000
(Filed With SEC on February 12, 2019)
-
AGREEMENT BY AND BETWEEN KCL THERAPEUTICS, INC. AND HARRY LANDER
(Filed With SEC on January 25, 2019)
